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Summary We studied the effects of high doses of pentobarbital (PB) and carba-
mazepine (CBZ) on electrolyte levels and pH in an epileptic animal model. Pento-
barbital decreased Ca2+ and Na+ levels without pentylenetetrazole (PTZ). After this,
Ca2+ and Na+ levels continued to decrease except when CBZ was used, which
preserved the Ca2+ levels PTZ may have opposed effects on PB. Our results suggest
that PB causes changes in electrolyte levels and pH, but these changes are diminished
by CBZ.
# 2007 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.Introduction
Oneof11peoplehasepilepsyproblems,experiencing
at least one seizure at somepoints. The tendencies to
have recurrent, unprovoked seizures occur with a
prevalence of about 0.5%, and a cumulative lifetime
prevalence of 3%. It cover different conditions with
varying etiology.1 Epilepsy is not a disease, but a
syndrome of different cerebral disorders of the
central nervous system, which is characterized by
paroxysmal, excessive, and discharges of large
numbers of neurons.2* Corresponding author. Tel.: +52 55 59 99 10 00x19303.
E-mail address: alfa1360@yahoo.com.mx
(A. Alfaro-Rodrı´guez).
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doi:10.1016/j.seizure.2007.02.010The conditions grouped under the term epilepsy
constitute an area of continuingmedical need. It has
been estimated that about 20% of the patients with
epilepsy using the first generation of antiepileptic
drugs (pentobarbital, phenytoin, carbamazepine,
sodium valproate and diazepam).1
Carbamazepine (CBZ) is one of the most effective
and regularly used antiepileptic drugs. This sub-
stance is effective in to manage various types of
epilepsy, including partial and generalized tonic—
clonic seizures.1
Pentobarbital is a major drug in the control for
canine, feline, and human epilepsy and can signifi-
cantly reduce the severity of seizures. PB raises the
threshold for seizure discharge and inhibits the
initiation, diffusion, and spread of discharge from. Published by Elsevier Ltd. All rights reserved.
398 R. Uribe-Escamilla et al.the neural focus. Blood-level PB is clinically effec-
tive 12—24 h after oral administration; it is meta-
bolized by the liver and extracted by the kidney. The
common side effects of PB are ataxia, sedation,
polyuria, polydipsia, polyphagia, and it may depress
both respiratory drive and mechanisms responsible
for the rhythmic character of respiration.2
Pentobarbital is a known inducer of microsomal
enzymes (cytochrome P-450 (CYP), NADPH-cyto-
chrome P-450 reductase, NADPH oxidase, glu-
tathione-S-tranferase), which are responsible for
the metabolic breakdown of a large number of
endogenous and exogenous chemical compounds.2
Studies in the last few years suggest that body
electrolytes may be involved in some types of epi-
lepsy and may increase the recurrence of seizures.
Reports point to the vital role of body electrolytes
sodium (Na+), potassium (K+), calcium (Ca2+), and
magnesium (Mg2+) for seizure conditions to develop.
No abnormality was noticed in serum Na+ in epilep-
tic patients during and after a seizure. With
unaltered Na+ level and hypokalemia patients,
increase in recurrence of seizures was noted. That
changes in Ca2+ levels are responsible for beginning
convulsions is well documented.3
Epilepsy is characterized by recurrent seizures
occurring overlong periods of time, kindled seizures
are achieved by electrical or chemical stimulation.
Examples of chemicals produce kindling in rats
include pentylenetetrazole (PTZ), FG-7142, and
picrotoxin.4
Pentylenetetrazole induces prototypical sys-
temic seizure in epileptic rodents. The different
susceptibility of the cortical and subcortical struc-
tures to PTZ-induced drastic effects may be related
to their gamma aminobutyric acid type A (GABAA)
receptor density.5,6 Cognitive disorders were shown
to change with neuronal loss in the hippocampus.
The animal models offer an opportunity to examine
changes associated with epilepsy.7,8
PTZ-induced convulsions are linked with abnor-
mal electrical recordings of brain activity. The
beginning of seizures by PTZ is attributed to repress
GABAA receptor Cl-channel, which thus attenuates
GABA-dependent inhibition9 and/or activation or
N-metyl-D-aspartate (NMDA) receptors.10—12
GABA may mediate its synaptic events through
two types of receptors–—ionotropic and metabotro-
pic. Among ionotropic receptors associated with a
chloride channel so called GABAA and GABAC recep-
tors are distinguished–—metabotropic ones linked to
the cascade of second intraneuronal messengers
are GABAB receptors. GABAA receptor complex con-
sists of a number of binding sites for GABA itself,
benzodiazepines, barbiturates, ethanol and picro-
toxin which is a chloride channel blocker. WhenGABA binds to its recognition site on the GABAA
receptor complex, an opening of the chloride
channel occurs with the subsequent influx of
chloride anions into a neuron, resulting in its
hyperpolarization.3
Therefore, in this research, we directly proposed
to evaluate the effect on the levels of some elec-
trolytes (Ca2+, Na+ and K+), and pH, and HCO3 levels
after seizures are induced in animal subjects. Two
different anesthetics, PB and ketamine and xylazine
(KX) mixture and CBZ, were employed to compare
the impacts of PB in an attempt to establish an
adequate epileptic animal model and a good clinical
method to study and monitor animals in laboratory
experiments.Methods
Animals
Twenty adult male Wistar rats (mean body weight,
448.8 g) were used as subjects in this study. Rats
were housed five in a cage under a 12-h light/12-h
dark cycle; food and water were available and
administered ad libitum. Animals were treated
according to international standards on animal
handling. The procedure was approved by the Ethic
and Investigation Committees of the National Reha-
bilitation Institute of Mexico City.
The rats were divided into three groups:
Group 1: Rats (n = 5) were anesthetized with PB
90 mg/kg i.p. They received a dose of 90 mg/kg
body weight PTZ (Sigma, USA) dissolved in 0.9%
saline solution i.p.
Group 2: Rats (n = 5) were anesthetized with PB
90 mg/kg i.p. They received a dose of 50 mg/kg
body weight of CBZ i.p. and posteriori 30 min
90 mg/kg body weight PTZ i.p., dissolved in
0.9% saline solution.
Group 3: Rats (n = 5) were anesthetized with a
mixture of Ketamine 80 mg/kg and Xylazine
8 mg/kg IM. They received a dose of 90 mg/kg
body weight PTZ i.p. dissolved in 0.9% saline
solution.
Blood samples (400—500 ml) were taken from the
heart by cardiac puncture under anesthesia at two
different times: first, basal register previously at
PTZ and CBZ administration, and the second an hour
after PTZ injection; the number of serial bleeds did
not exceed 1%13 of the rat’s body weight; syringes
were heparinized with 1000 UI/mL of blood to get
electrolytes and do arterial blood gas measure-
ments.
Pentobarbital on pH and Electrolyte levels in epileptic rats 399pH, bicarbonate (HCO3a), sodium (Na), potassium
(K) and ionized calcium (ICa) were measured by a
blood gas analyzer (GEM mod. premier 3000).
Data analysis
For the experiments using blood gas and electrolytes
as variables, all values were expressed as mean
 standard error (S.E.). Results were analyzed by
the U-Mann—Whitney test (SPSS for windows,
release 10.0). In all cases, the probability of error
less than 0.05 were selected as the criterion for
statistical significance from control values.Results
During the study, we observed a mortality of 25%;
the final number of sample subjects was 15 rats
(n = 15). To compare PB effects on electrolytes,
we used another anesthetic in this study: the KX
mixture. We took basal results with anesthetic mix-
ture as normal values. Then, we analyzed the dif-
ferences between Groups 1 and 2 with basal samples
and noticed significant differences in pH, Na+ and
Ca2+ ( p  0.047, 0.035 and 0.009) (Table 1).
The next comparison was done with the treat-
ment involving PTZ administration after 1 h among
groups given PB and KX. There were significant
differences in pH, Na+ and Ca2+ ( p  0.016, 0.009
and 0.009), respectively (Table 1).
Then, we compared the basal response of animals
in Group 3 with those exposed to the PTZ treatment.
In this case, there were no significant differences
seen, except when we compared Group 1 basal and
after PTZ changes in Ca2+ (Table 1).
The rats in Groups 1 and 2 did not present appar-
ent seizures, waking up 5 or 10 min after PTZ. OnlyTable 1 pH and electrolyte levels basal and after Pentyl
Ketamine and Xilazine (KX), Carbamazepine (CBZ)
Variable Group 1 PB + PTZ Group 2 P
Basal 1 h Basal
pH 7.42  0.02a 7.40  0.02b 7.36  0
Na 147.20  3.14c 154.2  2.71d 150  2.97
K 3.8  0.31 3.46  0.20 4.04  0
Ca 0.99  0.12e 0.64  0.06f, g 0.73  0
HCO3 23.1  1.67 19.94  1.45 18.9  2.
Data are expressed as mean  S.E.M. Mann—Whitney Test.
a Significant compared to basal group 3, p = 0.047.
b Significant compared to 1 h group 3, p = 0.016.
c Significant compared to basal group 3, p = 0.035.
d Significant compared to 1 h group 3, p = 0.009.
e Significant compared to basal group 3, p = 0.009.
f Significant compared to basal group 1, p = 0.047.
g Significant compared to 1 h group 3, p = 0.009.those in Group 3 had seizures for 2 h about 2 min
after PTZ administration.Discussion
The main purpose of this experiment was to investi-
gate pentobarbital release in the pH and electrolyte
levels before and after induced seizure in rats. Sec-
ond, we employed pentobarbital rather than keta-
mine and xylazine (KX)mixture to investigate if there
are differences between the drugs effects because
we certainly consider that, the pentobarbital is bet-
ter anticonvulsant and anesthetic comparedwith the
ketamine and xylazine mixture.
The PTZ model of epilepsy, not only produces
epilepsy like seizure activity, but also mimics sei-
zure-induced cognitive and emotional changes that
are similar to what is observed in human epilepsy,
particularly those with temporal lobe foci,9,14 that’s
why this is a good model of epilepsy study.
The results of this study showed an increase of
Ca2+ extracellular levels in Ketamine anesthetized
animals, suggesting that it causes an inhibiting
depolarizing response due to the Ca2+ in the NMDA
receptors. For this argument, we took these issues
as normal values to compare and assess PB effects on
pH and electrolyte levels.
Ketamine is an anesthetic agent known to block
NMDA receptors, blocked T-type Ca2+ current.15
The body electrolytes play an essential role for
enabling seizure conditions to development; and
routine laboratory estimation of serum Na+, K+,
Mg2+, and Ca2+ is essential for the rational under-
standing and management of epileptic patients.16
PB increased the pH values (significance of
p  0.047) and increased Na+ (p  0.035), opposite
Ca2+ levels; this electrolyte decreased in Groups 1enetetrazol (PTZ) induced seizure; Pentobarbital (PB),
B + CBZ + PTZ Group 3 KX + PTZ
1 h Basal 1 h
.02 7.39  0.01 7.34  0.02 7.29  0.01
151.8  1.71 139.2  1.39 135.8  1.77
.60 3.28  0.13 3.54  0.15 3.98  0.26
.14 0.79  0.06 1.84  0.19 1.68  0.23
63 20.76  1.18 20.42  1.03 17.64  1.7
400 R. Uribe-Escamilla et al.and 2. This effect is important because PB facilitates
the inhibition of synapses GABAergics, inhibiting Na+
and Cl-channels. Investigators in 2003, indicate the
immobilizing action and part the hypnotic action of
pentobarbital is mediating by B3-containing GABAA
receptors.17
In contrast with others barbiturates, which exert
most if not all of their clinically relevant actions via
B2- and B3-containining GABAA receptors, the PB has
a wider range to targets, modulating the activity not
only GABAA receptors,
18 but also of nicotinic acet-
ylcholine receptors, AMPA receptors, kainate recep-
tors and glycine receptors.19
Slobodan and Christoper20 postulated importance
of at least some T-Ca2+ currents in the action of some
anticonvulsant drugs. All barbiturates and anaes-
thetics could produce complete blockade of T-Ca2+
current in rat.
Many documents show that a low-level of Ca2+ is
responsible for the initiation of convulsions9,21; in
this job, PB declined Ca2+ levels, probably because it
is a good anticonvulsive drug. With the KX mixture,
Ca2+ levels were higher than those with PB.
This response with KX explains why rats have
seizures with this anesthetic when we put PTZ.
However, with PB, rats did not have the seizures
and woke up after being given PTZ.
Studies have shown that severe epileptic seizures
lead to acute cerebral metabolic and circulatory
changes. Besides systemic changes such as acute
hypertension results from epileptic seizures, glu-
cose, having a fundamental importance in brain
oxidative metabolism, is increasingly carried and
consumed in the brain during epileptic seizures,
as a result of seizure activity.12,22
But, in this situation, we had changes in electro-
lytes and pH, only with PB. When we used KX,
changes in these parameters were not observed.
By exchanging intracellular H+ for extracellular
Na+, PB performs a fundamental role in various cell
roles, including pH control, volume homeostasis,
and cell growth,23 and can significantly lessen sei-
zure severity rate. PB raises the threshold for sei-
zure discharge and inhibits the beginning, diffusion,
and spread of discharge from the neural focus.24
The apparent contrasts in pH, Na+ and Ca2+, found
an hour after PTZ, are likely to be a direct conse-
quence of PB use. That are why it is considered the
middle life of this medicine.
In this course, PTZ could lead to epileptic seizures
without interfering greatly with metabolism.25 In
this particular situation, except in a chronic model,
these results could change.
Group 2 presents values similar to those shown
by Group 1, except that Ca2+ levels did not change
in Group 1 due to CBZ effects. CBZ works toblock changes in Ca2+, inhibited Ca2+ and Na+
channels.
CBZ blocks sustained repetitive firing in indivi-
dual neurons: this drastic effect is caused by the
blockade of voltage-dependent Na+ or Ca2+ chan-
nels.16 In this study, CBZ preserved Ca2+ levels in rats
after PB and PTZ. It is important to know what
happened with the neurotransmitter in these cases
because, in rats with PB and CBZ, when we put the
PTZ i.p., the rats woke up and did not have seizures.
Probably PTZ is opposing to PB.
These results indicate that drugs such as PB
creates changes in systemic electrolytes and pH
but these changes could be stopped with other drugs
like CBZ. This work is important because it gives an
adequate animal model for the study of epilepsy,
reveals the position of anesthetics in this category of
work and gives alternating perceptions on how to
use electrolyte parameters to know the effect of
these drugs.
The results reflect the PB is a good anticonvulsive
drug for this decreasing in Ca2+ levels, to prevent
the induced seizures by PTZ in rats.References
1. Yogeeswari P, Sriram D, Pandeya SN, Stables JP. 4-Sulpha-
moylphenyl semicarbazones with anticonvulsant activity. Il
Farmaco 2004;59:609—13.
2. Demir O, Yazar E, Altunok V, Elmas M, Ozdemir V. Effect of
pentobarbital on antioxidant enzyme activities and blood
gas parameters in Balb/C mice. Revue Me´d Ve´t 2001;152:
723—6.
3. Hamed SA, Abdellah MM, El-Melegy N. Blood levels of trace
elements, electrolytes, and oxidative stress/antioxidant
systems in epileptic patients. J Pharmacol Sci 2004;96:
465—73.
4. Van Camp N, D’Hooge R, Verhoye M, Peeters R, De Deyn P,
Vander Linden A. Simultaneous electroencephalographic
recording and functional magnetic resonance imaging during
pentylenetetraol-induced seizures in rat. NeuroImage
2003;19:627—36.
5. Schmoll H, Badan I, Grecksch G, Walker L, Kessler C, Popa-
Wagner A. Kindling status in Sprague—Dawley rats induced by
pentylenetetrazole. Am J Pathol 2003;162:1027—34.
6. Park JH, Cho H, Kimb H, Kima K. Repeated brief epileptic
seizures by pentylenetetrazole cause neurodegeneration and
promote neurogenesis in discrete brain regions of freely
moving adult rats. Neuroscience 2006;140:673—84.
7. Pavlova T, Stepanichev M, Gulyaeva N. Pentylenetetrazole
kindling induces neuronal cyclin B1 expression in rat hippo-
campus. Neurosci Lett 2006;392:154—8.
8. Mortazavi F, Ericson M, Story D, Hulce VD, Dunbar GL. Spatial
learning deficits and emotional impairments in pentylenete-
trazole-kindled rats. Epilepsy Behav 2005;7:629—38.
9. Kiviranta T, Tuomisto L, Airaksine EM. Osmolarity and elec-
trolytes in cerebrospinal fluid and serum of febrile children
with and without seizures. Eur J Pediatr 1996;155:120—5.
10. Yahyavi-Firouz-Abadi N, Tahsili-Fahadan P, Riazi K, Hossein M,
Reza A. Involvement of nitric oxide pathway in the acute
Pentobarbital on pH and Electrolyte levels in epileptic rats 401anticonvulsant effect of melatonin in mice. Epilepsy Res
2006;68:103—13.
11. Ali A, Ahmad FJ, Pillai KK, Vohora D. Evidence of the anti-
epileptic potential of amiloride with neuropharmacological
benefits in rodent models of epilepsy and behavior. Epilepsy
Behav 2004;5:322—8.
12. Ceyhan M, Kayir H, Uzbay IT. Investigation of the effects of
tianeptine and fluoxetine on pentylenetetrazole-induced
seizures in rats. J Psychiatric Res 2005;39:191—6.
13. Marshall S, Milligan A, Yates R. Experimental techniques and
anaesthesia in the rat and mouse. ANZCCART News 1994;7:
1—4.
14. Cornford EM, Nguyen EV, Landaw EM. Acute upregulation of
blood—brain barrier glucose transporter activity in seizures.
Am J Physiol Heart Circ Physiol 2000;279:H1346—54.
15. Zeller A, Arras M, Jurd R, Rudolph U. Identification of a
molecular target mediating the general anesthetic actions
of pentobarbital. Mol Pharmacol 2006;12. [Epub ahead of
print].
16. Czapinski P, Blaszczyk B, Czuczwar SJ. Mechanisms of
action of antiepileptic drugs. Curr Topics Med Chem
2005;5:3—14.
17. Jurd R, Arras M, Lambert S, Drexler B, Siegwart R, Crestani F,
et al. General anesthetic actions in vivo strongly attenuated
by a point mutation in the GABA(A) receptor beta3 subunit.
FASEB J 2003;17(2):250—2.18. Thompson SA, Whiting PJ, Wafford KA. Barbiturate interac-
tions at the human GABAA receptor: dependence on receptor
subunit combination. Br J Pharmacol 1996;117(3):521—7.
19. Krasowski MD, Harrison NL. General anaesthetic actions on
ligand-gated ion channels. Cell Mol Life Sci 1999;55(10):
1278—303.
20. Slobodan M, Christoper J. Pharmacological properties of T-
type Ca2+ Current in adult rat sensory neurons: effects of
anticonvulsant and anesthetic agents. J Neurophysiol
1998;79:240—58.
21. Nzeh DA, Erasmus RT, Aiyedun BA. Serum electrolytes and
protein changes after intravenous injection of sodium and
meglumine diatrizoate. Afr J Med Sci 1992;23:35—7.
22. Nitsch C, Suzuki R, Fujiwara K, Klatzo I. Incongruence of
regional cerebral blood flow increase and blood—brain bar-
rier opening in rabbits at the onset of seizures induced by
bicuculline, methopyridoxine and kainic acid. J Neurol Sci
1985;67:67—79.
23. Grinstein S, Rothstein A. Mechanisms of the regulation of the
Naþ/Hþ exchanger. J Membr Biol 1986;90:1—12.
24. Eloqayli H, Dahl CB, Go¨testam KG, Unsga˚rd G, Sonnewald U.
Changes of glial—neuronal interaction and metabolism after
a subconvulsive dose of pentylenetetrazole. Neurochem Int
2004;45:739—45.
25. Krapf R, Alpern RJ. Cell pH and transepithelial transport in
the renal proximal tubule. J Membr Biol 1993;131:1—10.
